by Staff Writers
Shanghai (AFP) Jan 20, 2017
China's state-owned chemical corporation ChemChina has asked US anti-trust regulators to greenlight its $43 billion acquisition of Swiss seed giant Syngenta, a report said Friday.
China National Chemical Corp (ChemChina) has filed for approval from the Federal Trade Commission and the process is on track, Bloomberg News reported.
Winning the approval is a critical step towards wrapping up the biggest overseas takeover ever for a Chinese firm.
US regulators have been a stumbling block for other Chinese deals. In December, American President Barack Obama blocked a Chinese company's purchase of German semiconductor equipment maker Aixtron over security concerns, resulting in the termination of the deal a few days later.
Bloomberg said the proposed deal, announced last February, has faced delays as competition authorities are concerned the acquisition might raise prices or reduce choice for crop-protection products sold to farmers, and ChemChina has extended its offer for Syngenta numerous times.
The EU announced in November that it would probe the deal to see if it would hurt competition as ChemChina also controls Adama, the largest supplier of generic crop protection products in Europe.
ChemChina aims to obtain all regulatory approval in the first quarter of this year, its latest filings showed.
The Chinese firm did not immediately respond to a request for comment.
Space Technology News - Applications and Research
|The content herein, unless otherwise known to be public domain, are Copyright 1995-2017 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement|